StockData
Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc. (OTLK) stock

OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30
$0.41+0.05 (+13.12%)

Close on Nov 18, 2026Market cap $99.30MP/E –Yield –

Outlook Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 4.0%.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Sep 30, 20254.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2025CQ2 2025Jun 30, 202570.8%–

More Outlook Therapeutics figures

See a number that looks wrong?